Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection

Journal of Vascular Surgery

Volumn 36, Issue 5, 2002, Pages 1027-1030

  Ghiselli, Roberto ^a,b,c   Giacometti, Andrea ^a,b,c   Cirioni, Oscar ^a,b,c   Mocchegiani, Federico ^a,b,c   Orlando, Fiorenza ^a,b,c   Kamysz, Wojciech ^a,b,c   Del Prete, Maria Simona ^a,b,c   Lukasiak, Jerzy ^a,b,c   Scalise, Giorgio ^a,b,c   Saba, Vittorio ^a,b,c  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b Biotechnology Centre   (Italy)

^c MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFAZOLIN; METICILLIN; OXACILLIN; PEPTIDE DERIVATIVE; TEMPORIN A; UNCLASSIFIED DRUG; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM CONTAMINATION; BLOOD VESSEL GRAFT; CONTROLLED STUDY; DRUG EFFICACY; GRAFT INFECTION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; OUTCOMES RESEARCH; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROPHYLAXIS; RAT; STAPHYLOCOCCUS EPIDERMIDIS;

EID: 0036847490     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1067/mva.2002.127530     Document Type: Article

References (31)

1. Von Eiff C, Heilmann C, Peters G. New aspects in the molecular basis of polymer-associated infections due to staphylococci. Eur J Clin Microbiol Infect Dis 1999;18:853-6.
2. Barie PS. Antibiotic-resistant gram-positive cocci: Implications for surgical practice. World J Surg 1998;22:118-26.
3. Henke PK, Bergamini TM, Rose SM, Richardson JD. Current opinion in prosthetic vascular graft infection. Am Surg 1998;64:39-45.
4. Bergamini TM, Corpus RA Jr, Brittian KR, Peyton JC, Cheadle WG. The natural history of bacterial biofilm graft infection. J Surg Res 1994;56:393-6.
5. Bergamini TM, Peyton JC, Cheadle WG. Prophylactic antibiotics prevent bacterial biofilm graft infection. J Surg Res 1992;52:101-5.
6. Monzon M, Oteiza C, Leiva J, Amorena B. Synergy of different antibiotic combinations in biofilms of Staphylococcus epidermidis. J Antimicrob Chemother 2001;48:793-801.
7. Sardelic F, Ao PY, Taylor DA, Fletcher JP, Prophylaxis against Staphylococcus epidermidis vascular graft infection with rifampicin-soaked, gelatin-scaled Dacron. Cardiovasc Surg 1996;4:389-92.
8. Giacometti A, Cirioni O, Ghiselli R, Goffi L, Mocchegiani F, Riva A, et al. Polycationic peptides as prophylactic agents against methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis vascular graft infection. Antimicrob Agents Chemother 2000;44:3306-9.
9. Chervu A, Moore WS, Gelabert HA, Colburn MD, Chvapil M. Prevention of graft infection by use of prostheses bonded with a rifampin collagen release system. J Vase Surg 1991;14:521-4.
10. Cannon M. A family of wound healers. Nature 1987;328:478.
11. Bevins CL, Zasloff M. Peptides from frog skin. Annu Rev Biochem 1990;59:395-414.
12. Clark DP, Durell S, Maloy WL, Zasloff M. Ranalexin: A novel antimicrobial peptide from bullfrog (Rana catasbeiana) skin, structurally related to the bacterial antibiotic polymyxin. J Biol Chem 1994;269:10849-55.
13. Kim JB, Halverson T, Basir YJ, Dulka J, Knoop FC, Abel PW, et al. Purification and characterization ofantimicrobial and vasorelaxant peptides from skin extracts and skin secretions of the North American pig frog Rana grylio. Regul Pept 2000;90:53-60.
14. Mangoni ML, Rinaldi AC, Di Giulio A, Mignogna G, Bozzi A, Barra D, et al. Structure-function relationships oftemporins, small antimicrobial peptides from amphibian skin. Eur J Biochem 2000;267:1447-54.
15. Rinaldi AC, Di Giulio A, Liberi M, Gualtieri G, Oratore A, Bozzi A, et al. Effects of temporins on molecular dynamics and membrane permeabilization in lipid vesicles. J Pept Res 2001;58:213-20.
16. Simmaco M, Mignogna G, Canofeni S, Miele R, Mangoni ML, Barra D. Temporins, antimicrobial peptides from the European red frog Rana temporaria. Eur J Biochem 1996;242:788-92.
17. Harjunpaa I, Kuusela P, Smolucb MT, Silberring J, Lankinen H, Wade D, Comparison of synthesis and antibacterial activity of temporin A. FEBS Lett 1999;449:187-90.
18. Wade D, Silberring J, Soliymani R, Heikkinen S, Kilpelainen I, Lankinen H, et al. Antibacterial activities of temporin A analogs. FEBS Lett 2000;479:6-9.
19. National Committee for Clinical Laboratory Standards. Approved Standards M7-A3. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Wayne (PA): National Committee for Clinical Laboratory Standards; 1997.
20. Giacometti A, Cirioni O, Barchiesi F, Del Prete MS, Fortuna M, Caselli F, et al. In vitro susceptibility tests for cationic peptides: Comparison of microbroth dilution methods for bacteria that grow aerobically. Antimicrob Agents Chemother 2000;44:1694-6.
21. Bergamini TM, Corpus RA Jr, McCurry TM, Peyton JC, Brittian KR, Cheadle WG. Immunosuppression augments growth of graft-adherent Staphylococcus epidermidis. Arch Surg 1995;130:1345-50.
22. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis emerging resistance and need for alternative agents. Clin Infect Dis 1998;26:1182-7.
23. Biavasco F, Vignaroli C, Varaldo PE. Glycopeptide resistance in coagulasenegative staphylococci. Eur J Clin Microbiol Infect Dis 2000;19:403-17.
24. McManus AT, Goodwin CW, Pruitt BA Jr. Observations on the risk of resistance with the extended use of vancomycin. Arch Surg 1998;133:1207-11.
25. Goraya J, Wang Y, Li Z, O'Flaherty M, Knoop FC, Platz JE, et al. Peptides with antimicrobial activity from four different families isolated from the skins of the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens. Eur J Biochem 2000;267:894-900.
26. Jack RW, Tagg JR, Ray B. Bacteriocins of Gram-positive bacteria. Microbiol Rev 1995;59:171-200.
27. Moore AJ, Beazley WD, Bibby MC, Devine DA. Antimicrobial activity of cecropins. J Antimicrob Chemother 1996;37:1077-89.
28. Sahl HG, Jack RW, Bierbaum G. Biosynthesis and biological activities oflantibiotics with unique post-translational modifications. Eur J Biochem 1995;230:827-53.
29. Harvey PA, Alcid DV, Greco RS. Antibiotic bonding to polytetrafluoroethylene with tridodecylmethylammonium chloride. Surgery 1982;92:504-12.
30. Phaneuf MD, Quist WC, Bide MJ, LoGerfo FW. Modification of the polyethylene terephthalate (Dacron) via denier reduction: Effects on material tensile strength, weight, and protein binding capabilities. J Appl Biomater 1995;6:289-99.
31. Hancock REW. Peptides antibiotics. Lancet 1997;349:418-22.